Atlas Trials

VectivBio AG

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch VectivBio AG

RecordFirmDate
A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF) (NCT07742735)VectivBio AG2026-08-01
Relative Bioavailability of a New Presentation of Apraglutide Versus the Reference Formulation (NCT06002555)VectivBio AG2023-05-23
Evaluation of Apraglutide on Gastric Emptying (NCT05995704)VectivBio AG2023-03-02
A Phase 1 Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Hepatic Function (NCT05706623)VectivBio AG2023-01-30
Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD) (NCT05415410)VectivBio AG2022-05-25
Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. (NCT05018286)VectivBio AG2021-07-13
Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC) (NCT04964986)VectivBio AG2021-06-14
Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF (NCT04627025)VectivBio AG2021-01-26
Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function. (NCT04699032)VectivBio AG2020-12-08

Track VectivBio AG automatically

Every clearance here is in the API, with alerts when new ones post.